REG - EnSilica PLC - Result of GM, Major New Shareholder and TVR

EnSilicaAnnouncement

Tue 11:30

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260407:nRSG4866Za&default-theme=true

RNS Number : 4866Z  EnSilica PLC  07 April 2026

7 April 2026

NEWS RELEASE

("EnSilica", the "Company" or the "Group")

 

Result of General Meeting, Welcome to New Substantial Shareholder & Total
Voting Rights

 

EnSilica plc (AIM: ENSI), a leading fabless, application-specific
chipmaker, announces that at the general meeting of the Company held earlier
today, all resolutions were duly passed. The results of the proxy voting will
be available on the Company's website in due course.

 

As a result of the resolutions being passed today, the Second Tranche Placing
and the Retail Offer as announced on 13 March 2026 and 18 March 2026 can now
proceed to completion. It is expected that Admission will become effective and
dealings in the new Ordinary Shares will commence on AIM at 8.00 a.m. on 8
April 2026.

 

Welcome to new substantial shareholder

 

The board of directors of EnSilica looks forward to welcoming Esterhuyzen
Limited ("Esterhuyzen") as a substantial shareholder following Esterhuyzen's
participation in the Second Tranche Placing. Esterhuyzen participated in the
First Tranche Placing and, as announced on 19 March 2026, currently holds
8,000,000 Ordinary Shares, representing 7.53 per cent. of the Company's
current issued share capital. Following Esterhuyzen's participation in the
Second Tranche Placing, Esterhuyzen is expected to hold 16,000,000 Ordinary
Shares, representing 13.57 per cent. of the enlarged issued share capital from
Admission.

 

Esterhuyzen Limited is a privately held family office investment holding
company with a particular focus on the pan European semiconductor sector.
Esterhuyzen Limited's investment approach is long-term, and they are
supportive of the Company's existing strategic direction.

 

Changes to significant shareholdings in the Company

 

With the completion of the Fundraising, the Company is aware of dilution to
the following significant shareholders in the Company whose percentage
interests on Admission is expected to be as follows:

 

 Name                  Total number of Ordinary Shares held                   Percentage of issued share capital held on Admission
 Ian Lankshear                               16,040,358                       13.61%
 Richard Ashley Hamer              5,857,490                                  4.97%
 Marc Castells                        5,746,554                               4.88%
 Richard Neil Marley                4,771,554                                 4.05%
 Alan Chi Wai Wong                        3,400,000                           2.88%
 Andrew Peter Maund                         3,310,237                         2.81%

 

 

Total Voting Rights

 

Upon Admission, the Company's issued share capital will consist of 117,877,230
Ordinary Shares with one voting right each. The Company does not hold any
Ordinary Shares in treasury. Therefore, the total number of Ordinary Shares
and voting rights in the Company will be 117,877,230. With effect from
Admission, this figure may be used by shareholders in the Company as the
denominator for the calculations by which they will determine if they are
required to notify their interest in, or a change to their interest in, the
share capital of the Company under the FCA's Disclosure Guidance and
Transparency Rules.

 

Terms used but not defined in this announcement have the same meaning as set
out in the Company's announcement released at 4:35 p.m. on 12 March 2026.

 

 

 EnSilica plc                                                           via Novella Communications

 Ian Lankshear, Chief Executive Officer                                 +44 (0)20 3151 7008

 Kristoff Rademan, Chief Financial Officer

 www.ensilica.com (http://www.ensilica.com)

 Allenby Capital Limited (Nominated Adviser & Joint Broker)

 Jeremy Porter / Vivek Bhardwaj (Corporate Finance)                     +44 (0)20 3328 5656

 Joscelin Pinnington / Tony Quirke (Sales & Corporate Broking)          info@allenbycapital.com (mailto:info@allenbycapital.com)

 Panmure Liberum Limited (Joint Broker)

 Edward Mansfield / Will King / Phoebe Bunce                            +44 (0)20 3100 2000

 Novella Communications (Investor & Financial Public Relations)         +44 (0)20 3151 7008

 Tim Robertson / Aeliya Bilgrami                                        ensilica@novella-comms.com (mailto:visum@vigoconsulting.com)

 

About EnSilica plc

EnSilica is a fabless, application-specific chipmaker, combining deep domain
and system-level expertise with world-class capability in RF, mmWave,
mixed-signal and complex digital IC design. The Company serves customers
across the space and communications, industrial, automotive and healthcare
markets, where safety and security and reliability are critical.

A growing portfolio of reusable IP and silicon platforms underpins a
repeatable, scalable delivery model, reducing development risk, cost and time
to market while supporting long-term supply revenues. EnSilica has a strong
track record of delivering production-proven silicon to demanding industry
standards. Headquartered near Oxford, UK, the Company operates design centres
across the UK, India, Brazil and Hungary.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MSCBDLFBQZLLBBX



            Copyright 2019 Regulatory News Service, all rights reserved